These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31066440)

  • 1. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
    Klaassen MAY; Imhann F; Collij V; Fu J; Wijmenga C; Zhernakova A; Dijkstra G; Festen EAM; Gacesa R; Vich Vila A; Weersma RK
    J Crohns Colitis; 2019 Oct; 13(11):1439-1449. PubMed ID: 31066440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
    von Martels JZH; Bourgonje AR; Klaassen MAY; Alkhalifah HAA; Sadaghian Sadabad M; Vich Vila A; Gacesa R; Gabriëls RY; Steinert RE; Jansen BH; Bulthuis MLC; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; de Vos P; van Goor H; Faber KN; Harmsen HJM; Dijkstra G
    J Crohns Colitis; 2020 Jun; 14(5):595-607. PubMed ID: 31873717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
    Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
    Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects.
    Collij V; Imhann F; Vich Vila A; Fu J; Dijkstra G; Festen EAM; Voskuil MD; Daly MJ; Xavier RJ; Wijmenga C; Zhernakova A; Weersma RK
    PLoS One; 2019; 14(1):e0211328. PubMed ID: 30703110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
    Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
    Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study.
    Walton C; Montoya MP; Fowler DP; Turner C; Jia W; Whitehead RN; Griffiths L; Waring RH; Ramsden DB; Cole JA; Cauchi M; Bessant C; Naylor SJ; Hunter JO
    Eur J Clin Nutr; 2016 Sep; 70(9):1052-6. PubMed ID: 27167669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
    J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
    Zhang Z; Taylor L; Shommu N; Ghosh S; Reimer R; Panaccione R; Kaur S; Hyun JE; Cai C; Deehan EC; Hotte N; Madsen KL; Raman M
    J Crohns Colitis; 2020 Nov; 14(11):1547-1557. PubMed ID: 32343765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred.
    Ijaz UZ; Quince C; Hanske L; Loman N; Calus ST; Bertz M; Edwards CA; Gaya DR; Hansen R; McGrogan P; Russell RK; Gerasimidis K
    PLoS One; 2017; 12(2):e0172605. PubMed ID: 28222161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
    Bolte LA; Vich Vila A; Imhann F; Collij V; Gacesa R; Peters V; Wijmenga C; Kurilshikov A; Campmans-Kuijpers MJE; Fu J; Dijkstra G; Zhernakova A; Weersma RK
    Gut; 2021 Jul; 70(7):1287-1298. PubMed ID: 33811041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.
    Galazzo G; Tedjo DI; Wintjens DSJ; Savelkoul PHM; Masclee AAM; Bodelier AGL; Pierik MJ; Jonkers DMAE; Penders J
    J Crohns Colitis; 2019 Sep; 13(10):1273-1282. PubMed ID: 30810207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response.
    Dunn KA; Moore-Connors J; MacIntyre B; Stadnyk A; Thomas NA; Noble A; Mahdi G; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
    Inflamm Bowel Dis; 2016 Nov; 22(11):2607-2618. PubMed ID: 27760077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding polyphenol metabolism in patients with Crohn's disease: Insights from diet, gut microbiota, and metabolites.
    Xiang L; Zhuo S; Luo W; Tian C; Xu S; Li X; Zhu Y; Feng R; Chen M
    Food Res Int; 2024 Sep; 192():114852. PubMed ID: 39147529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
    Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
    Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.
    Cruz-Lebrón A; D'argenio Garcia L; Talla A; Joussef-Piña S; Quiñones-Mateu ME; Sékaly RP; de Carvalho KIL; Levine AD
    J Crohns Colitis; 2020 Jul; 14(6):791-800. PubMed ID: 31758685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
    Leibovitzh H; Lee SH; Xue M; Raygoza Garay JA; Hernandez-Rocha C; Madsen KL; Meddings JB; Guttman DS; Espin-Garcia O; Smith MI; Goethel A; Griffiths AM; Moayyedi P; Steinhart AH; Panaccione R; Huynh HQ; Jacobson K; Aumais G; Mack DR; Abreu MT; Bernstein CN; Marshall JK; Turner D; Xu W; ; Turpin W; Croitoru K
    Gastroenterology; 2022 Nov; 163(5):1364-1376.e10. PubMed ID: 35850197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.